GLP-1
Why it moved: −3 points at 18:24 UTC, after Bloomberg.com: Kroger to Invest $5 Billion on Improving Value, Lowering Prices — the latest article on its stories before the jump; what followed, not what caused it.
Price data
| Time | Chance of yes |
|---|---|
| now | 87% |
| 20 Oct, 18:24 UTC | 83% |
| 19 Oct, 16:52 UTC | 86% |
Your call. How does this end?
Free, no money involved. Calls are scored against the market's price when you make them, so backing an underdog that wins scores most. Leaderboard · Your calls
Does the market have this right?
Email me when the odds move
What counts
The market resolves to Yes if a Kroger representative mentions GLP-1 during the upcoming earnings call or its question-and-answer session. It resolves to No if no one says the word in that specific event. Readers often mistake this for a prediction about whether Kroger will actually sell GLP-1 drugs, but it only tracks whether the term is spoken.
Written from Kalshi's resolution rules by the same model that writes our headlines. The rules on Kalshi are what decides it.
Outcomes
- Yes 87%
- No 13%